Thrombectomy Under Reopro Versus Alteplase to Treat Stoke "TURANDOT"


Phase 4 Results N/A

Summary of Purpose

Intravenous (IV) Alteplase (rt-PA) is the gold standard for brain infarction within 4 h 30 of symptoms onset. Efficacy of this therapy is limited in the setting of large artery occlusions. For middle cerebral artery occlusions (MCA)or internal carotid artery occlusions (ICA), recanalization rates will drop as low as 10%. This element is critical as prognosis is linked to recanalization. Arterial re-occlusions are...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 24 April 2014.

1 Sep 2013 16 Dec 2013 1 Feb 2015 1 Feb 2015 1 Apr 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment